(Q73260241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Immunopathogenesis of hepatitis C virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

Kyong-Mi Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Clinics in liver disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

89-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

Parenterally transmitted non-A, non-B hepatitis: Virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Genetic organization and diversity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Structure and organization of the hepatitis C virus genome isolated from human carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Nucleotide sequence and mutation rate of the H strain of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Cell mediated immune response to the hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Innate immune recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Lymphokine production by human T cells in disease states

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Immunology. Licence to kill.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

To kill or to cure: options in host defense against viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

A new look at T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

HLA-peptide tetrameric complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Viral markers in the treatment of hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Immunity in hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Long-term persistence of hepatitis C virus antibodies in a single source outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Hepatitis C infection in African Americans: its natural history and histological progression

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

The liver as a site of T-cell apoptosis: graveyard, or killing field?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900068-5

7 January 2021

10.1016/S1089-3261(02)00068-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691460%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference